Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of ASKC202 With or Without ASK120067 [Phase 1]

View source ↗

Summary

Phase 1 clinical trial to assess safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of ASKC202 with or without ASK120067 in advanced sol…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• ASK120067
• ASKC202

Snippet

Sponsor: Jiangsu Aosaikang Pharmaceutical Co., Ltd. | Conditions: Advanced Solid Tumor | Phase 1 | Status: RECRUITING